Schneider Stefan, Linnhoff Dagmar, Ilg Ansgar, Salzmann Gian M, Ossendorff Robert, Holz Johannes
OrthoCentrum Hamburg, 20149 Hamburg, Germany.
Gelenkzentrum Rhein-Main, 65239 Hochheim am Main, Germany.
J Clin Med. 2025 Mar 23;14(7):2194. doi: 10.3390/jcm14072194.
: The treatment of cartilage damage is an ongoing challenge. Several techniques have been developed to address this problem. Matrix-Induced Autologous Chondrocyte Implantation (MACI) is often referred to as the "gold standard" for cartilage treatment. Numerous long-term outcome studies also have reported favorable results with Autologous Matrix-Induced Chondrogenesis (AMIC). Minced Cartilage Implantation (MCI) is a recently developed arthroscopic method. This technique has demonstrated promising outcomes, with the prospect of longer-term results still under investigation. This study aims to directly compare the patient-reported outcomes of these three techniques over a 2-year follow-up period. : A total of = 48 patients were included in the retrospective matched pair analysis ( = 16 MACI, = 16 AMIC, = 16 MCI). VAS, KOOS-Pain, and KOOS-Symptoms scores served as primary outcomes; the KOOS-ADL and -QOL and the Tegner Activity Scale (TAS) served as secondary outcomes. : All three groups did not differ from each other in the primary or secondary outcomes. Pain and function significantly improved from pre-surgery to two years after (VAS: < 0.000; ES: η = 0.27; KOOS-Pain: < 0.000; ES: η = 0.30; KOOS-Symptoms: = 0.000; ES: η = 0.26; KOOS-ADL: > 0.000; ES: η = 0.20; KOOS-QOL: > 0.000; ES: η = 0.30). There was no significant effect of time on the activity level. : All three procedures show good patient-reported outcomes, low complication rates, and long graft longevity in the 2-year follow-up. Therefore, all three methods seem to be equally recommendable for the treatment of cartilage lesions.
软骨损伤的治疗一直是一项挑战。人们已经开发了多种技术来解决这一问题。基质诱导自体软骨细胞植入术(MACI)常被称为软骨治疗的“金标准”。大量长期疗效研究也报告了自体基质诱导软骨生成术(AMIC)的良好效果。碎软骨植入术(MCI)是一种最近开发的关节镜技术。该技术已显示出有前景的结果,其长期效果仍在研究中。本研究旨在在2年的随访期内直接比较这三种技术患者报告的疗效。:共有48例患者纳入回顾性配对分析(16例MACI,16例AMIC,16例MCI)。视觉模拟评分法(VAS)、膝关节损伤与骨关节炎疗效评分量表疼痛(KOOS-Pain)和症状(KOOS-Symptoms)评分作为主要疗效指标;膝关节损伤与骨关节炎疗效评分量表日常生活能力(KOOS-ADL)、生活质量(KOOS-QOL)以及特格纳活动量表(TAS)作为次要疗效指标。:三组在主要或次要疗效指标上均无差异。从术前到术后两年,疼痛和功能显著改善(VAS:P<0.000;效应量:η=0.27;KOOS-Pain:P<0.000;效应量:η=0.30;KOOS-Symptoms:P=0.000;效应量:η=0.26;KOOS-ADL:P>0.000;效应量:η=0.20;KOOS-QOL:P>0.000;效应量:η=0.30)。时间对活动水平无显著影响。:在2年的随访中,所有三种手术均显示出良好的患者报告疗效、低并发症发生率和较长的移植物寿命。因此,对于软骨损伤的治疗,这三种方法似乎同样值得推荐。